Back

Plasma metabolomic profiling of patients with acute coronary syndrome treated with potent platelet inhibitors

20 February 2026 (09:45 - 10:30)
Organised by: Logo
Congress Presentation Part of: Poster session (2) - Pharmacology and pharmacotherapy Antiplatelet Drugs EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Mr Jovan Rogozarski

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Professor M. Valgimigli (Lugano, CH)
Abstract Slides
Presentation thumbnail
Doctor A. Laino (Naples, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Emara (Menoufia, EG)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster session (2) - Pharmacology and pharmacotherapy

The Event

Event poster

EAPCI Summit 2026

20 February 2026 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy
31 August 2019
thumbnail
Congress Presentation
Associations between plasma metabolite profiles and blood pressure: the HELIUS study
27 August 2021
thumbnail
Congress Presentation
Plasma trimethylamine-N-oxide is an independent predictor of long-term cardiovascular mortality in patients undergoing percutaneous coronary intervention for acute coronary syndrome
29 June 2021
thumbnail
Congress Session
French symposium: future directions in the treatment of acute coronary syndromes
26 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources